DRIO Stock UPDATES Labstyle (DRIO) 0.1250 09/06/2014 10:09:2

New Post Public Reply Private Reply Replies (0) Message Board

Sep 6, 2014 at 11:09 AM

Labstyle (DRIO) 0.1250 $DRIO

OTC Daily Trading News: Evoq Properties, Inc. MedBox, Inc. LabStyle Innovations Corp, MyEcheck, Inc. Elite Pharmaceuticals, Inc.
PR Newswire Europe - Tue Aug 19, 10:11AM CDT
LONDON, August 19, 2014 /PRNewswire/ --

LabStyle Innovations Reports 2014 Second Quarter Results and Anticipated Milestones for the Remainder of the Year
PR Newswire - Fri Aug 15, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported its financial and operational results for the three and six months period ending June 30, 2014. The company also presented an overview of results of the Dario(TM) smart meter soft launch, recent corporate achievements and anticipated milestones for the remainder of 2014.

LabStyle Innovations Announces the Initial Launch of the Dario(TM) Diabetes Management Solution for Android Devices
PR Newswire - Thu Jul 31, 8:50AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that the company has released the Dario(TM) Diabetes Management App for Android smartphone users. The mobile application will have the same user interface and features as the iOS Dario(TM) Application and will be available in select soft launch markets, including the United Kingdom and New Zealand.

LabStyle Innovations wins Israeli Ministry of Health's approval to market the Dario Smart Meter to people living with diabetes in Israel
M2 - Tue Jul 29, 6:09AM CDT
Diabetes management company LabStyle Innovations (Other OTC

RIO) disclosed on Monday the receipt of the Israeli AMAR's approval for the marketing and sale of the Dario Smart Meter in Israel.

LabStyle Innovations Receives Israeli Ministry of Health Approval for the Dario(TM) Smart Meter
PR Newswire - Mon Jul 28, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that it has received approval from the Israeli AMAR for the marketing and sale of the Dario(TM) Smart Meter in Israel. The Israeli AMAR is a unit in the Ministry of Health and is responsible for certification of all activities concerning medical devices import, sale and export and is a precondition for the sale of medical devices in Israel.

LabStyle Innovations Corp.'s CEO Erez Raphael Interviewed by The Life Sciences Report
Marketwire - Thu Jul 17, 8:25AM CDT
Having a chronic disease like diabetes engenders a sense of isolation that hasn't been adequately addressed by technology until now. With Dario, LabStyle Innovations Corp. (OTCQB: DRIO) has created a device that not only provides vital medical information to a diabetic patient in real time, but also connects that patient to a community of care providers, family, and online resources. In this interview with The Life Sciences Report, LabStyle President and CEO Erez Raphael describes how the Dario software platform could provide sufferers of other chronic diseases with the benefits of real-time data and community as well.

LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors
PR Newswire - Thu Jul 10, 11:00AM CDT
LabStyle Innovations Corp. (OTCQB

RIO), developer of the Dario(TM) Diabetes Management Solution, today announced the appointment of Professor Richard B. Stone as an independent member of its Board of Directors.

LabStyle Innovations to distribute its Dario Smart Meter, test strips and lancets in the Netherlands through Viper Medical
M2 - Thu Jul 10, 7:35AM CDT
LabStyle Innovations (OTCQB

RIO), a mobile health company that provides laboratory-testing products, reported on Wednesday the launch of an exclusive distribution agreement for its Dario Smart Meter, test strips and lancets in the Netherlands through Viper Medical.

LabStyle Innovations to Commence Sales of Dario(TM) in the Netherlands
PR Newswire - Wed Jul 09, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that the company is increasing its market reach by entering into an agreement with Viper Medical for exclusive distribution of the Dario(TM) Smart Meter, test strips and lancets in the Netherlands.

Falling Earnings Estimates Signal Weakness Ahead for Hansen Medical (HNSN) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 01, 7:35AM CDT
Hansen Medical one such stock considered to drop as it has witnessed a significant price decline and has seen negative earnings

LabStyle Innovations signs strategic distribution agreement in Canada for Dario Smart Meter, test strips and lancets
M2 - Mon Jun 30, 2:13AM CDT
Patented technolgy company LabStyle Innovations (Other OTC

RIO) reported on Friday the launch a strategic distribution agreement to grant the exclusive right to distribute the Dario Smart Meter, test strips and lancets in Canada to AutoControl Medical (ACM) .

LabStyle Innovations to Commence Sales of the Dario(TM) Smart Meter in North America
PR Newswire - Fri Jun 27, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that it has entered into a strategic distribution agreement with AutoControl Medical Inc. (ACM) that grants ACM the exclusive right to distribute the Dario(TM) Smart Meter, test strips and lancets in Canada.

LabStyle Innovations Awarded NHS Reimbursement Status in the United Kingdom for the Dario(TM) Smart Meter Strips and Lancets
PR Newswire - Wed Jun 25, 8:53AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO)announced today that it has been granted reimbursement status for strips and lancets to be utilized together with the patented Dario(TM) Smart Meter, effective September 1, 2014 in England, Wales, Scotland and Northern Ireland. Dario(TM) is a cloud-based, diabetes management solution which includes novel software applications combined with the stylish, 'all-in-one', pocket-sized, Dario Smart Meter which interfaces with a user's mobile device to form the overall Dario(TM) Diabetes Management Solution, allowing diabetics to monitor their blood sugars and other activities using their mobile devices.

LabStyle Innovations Reports Positive Results From the Initial Commercial Launch of Dario(TM) Smart Meter
PR Newswire - Tue Jun 17, 8:20AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today provided a positive update on the initial "soft" launch of the Dario(TM) Smart Meter in the company's initial target jurisdictions of the United Kingdom, Italy and New Zealand.

Renowned Diabetes Authority Dr. William Polonsky Joins LabStyle Innovations Medical/Scientific Advisory Board
PR Newswire - Wed Apr 02, 6:15AM CDT
LabStyle Innovations Corp. (OTCQB

RIO), developer of the Dario(TM) Diabetes Management Solution, today announced the appointment of Dr. William Polonsky to its Scientific/Medical Advisory Board.

IPOs and Transactions: March 17 - 21
PR Newswire - Mon Mar 24, 11:30AM CDT
There were 56 transactions filed with the SEC last week. Highlighted corporations and law firms include:

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sirha Lyon® 2027: A New Chapter in Foodservice

A Bold Step Forward There's a hearty aroma wafting from Lyon this January, and it's not just from the local gastronomy. Sirha Lyon® is queuing up for its 23rd edition, promising to turn the Foodservice and Hospitality sectors on their heads. Nearly 150,000 square meters of exhibition space packed to the rafters with over 4,300 exhibitors—this ain't your average trade...

BCG Pinpoints Fatal Ignorance in Critical Mineral Risks

Unseen Weakness in Industrial Giants Imagine staring right past a pothole while driving, then wondering why you keep popping your tires. That's where industrial companies find themselves today with critical minerals, according to a new wake-up call from Boston Consulting Group. The giant problem? Firms are blissfully unaware of the mosquitoes in their machines—tiny,...

Fulcra Unveils DIY Web App Tool for AI Agent Users

Fulcra Dynamics Pushes the Boundaries with New Tool There's always that moment when a company nudges the needle, and Fulcra Dynamics seems to have done just that with its latest release. They've unveiled an ingenious tool that promises a shake-up in how we build and use web applications with AI. It's the kind of move that makes you stop and wonder if we're witnessing the...

Skechers Facing Class Action: Investors Urged to Act

Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...

Gildan's Troubling Legal Struggles: Investor Action Alert

Gildan's Bumpy Ride: Legal Woes Unfold Well, folks, seems like Gildan Activewear Inc. (NYSE:GIL) is in for a bumpy ride, and not the kind that makes you feel alive, I tell ya. They've been slapped with a class action lawsuit, and the news ain't pretty. Accusations are flying hot about how they've been playing fast and loose with their financials. The Allegations: Channel...

OncoHost's Research Links TKI Sensitivity to Biology

Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...

Bladex Declares Quarterly Dividend for Q3 2026

Bladex's Steady Dividend: What's Under the Hood? Well, well, it looks like Bladex is doing the old dividend dance again. They've just announced a quarterly cash dividend of $0.6875 per share for the third quarter of 2026. It's scheduled for payout on November 24 to those who have their noses in the ledger come November 6—that's your record date, folks. Now, dividends...

Post University Expands with New Tech and Health Degrees

If you're looking to invest in an education with promising payoffs, you might look into what's cooking over at Post University. They've just dropped a bombshell of new programs sure to get some attention from tech heads and health nuts alike, and I can't help but think there's potential brewing here. New Academic Paths Emerge Post University isn't resting on its...

Nucor's Q3 2026 Earnings: Strong Growth Amid Steel Surge

Nucor's Solid Third Quarter Performance Nucor Corporation is flexing its muscles, reporting a robust third quarter for 2026. With net earnings hitting $1.32 billion and a diluted earnings per share of $5.80, the steel giant has shown it can more than hold its ground in a competitive market. Compare that to last quarter's $1.16 billion - we're seeing serious momentum....

Surgery Partners Buyout: Fair Deal or Insider Jackpot?

What's Going On With Surgery Partners? Alright, here's the scoop that shareholders can't ignore—Surgery Partners (NYSE:SGRY) could be heading under the scalpel itself with a proposed buyout by HealthSpan. For those holding onto SGRY stock, this might feel like watching the rerun of a medical drama where the ending ain't clear yet. Shareholders are set to get $23.50 a...